Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Wagner, Nikolaus B.; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; Gebhardt, Christoffer

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Autor(en):

Wagner, Nikolaus B.; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; Gebhardt, Christoffer

Tübinger Autor(en):

Wagner, Nikolaus B.
Weide, Benjamin Matthias
Garbe, Claus

Erschienen in:

Journal For Immunotherapy of Cancer (2019), Bd. 7, Article 343

Verlagsangabe:

Bmc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1186/s40425-019-0828-1

ISSN:

2051-1426